Recommendations for evaluating the safety of medicinal products containing nanoparticles
Recommendations for preclinical safety assessment of medicinal products containing nanoparticles are presented. The recommendations provide conditions for research acute and chronic toxicity of nanotherapeutics, methods for their quantitative and qualitative assessments.
Saved in:
Main Authors: | R. N. Alyautdin (Author), B. K. Romanov (Author) |
---|---|
Format: | Book |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2018-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Practical recommendations for screening of information on the drug safety
by: E. Yu. Pasternak, et al.
Published: (2018) -
Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results
by: Yu. V. Olefir, et al.
Published: (2018) -
THE LABELLING OF THE CONTAINERS FOR STORAGE AND TRANSPORTATION OF MEDICINAL PRODUCTS
by: A. P. Pereverzev, et al.
Published: (2018) -
THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
by: R. N. Alyautdin, et al.
Published: (2022) -
NEWS OF THE LEGISLATION IN THE SPHERE OF SAFETY OF MEDICINAL PRODUCTS IN THE RUSSIAN FEDERATION
by: B. K. Romanov
Published: (2018)